DES MOINES, Iowa, Feb. 9, 2016 /PRNewswire/ -- Eurofins Food Safety Systems announces the expansion into FSSC 22000 Global Food Certification Services. FSSC 22000 is a globally recognized, GFSI benchmarked certification standard that is based on existing ISO standards. Certification to this standard demonstrates a robust Food Safety Management System is in place. Certification to the FSSC 22000 scheme ensures consumer trust in the supply of safe food, beverages, food packaging, and animal feed.
"For several years, Eurofins has worked with Kemin on our American Feed Industry Association Safe Feed/Safe Food certification so I was confident in the level of service their team would provide," said Kemin Vice President of Regulatory Affairs Kristi Krafka. "Our Eurofins auditor was extremely knowledgeable about the standard, professional and helpful as Kemin completed the recertification process."
Eurofins Food Safety Systems is recognized for its efforts and capabilities in the field of food safety audits. As a certification body, Eurofins is accredited to audit in the GFSI benchmarked food safety standards. Eurofins provides value added assessments to manufacturers on a global basis. Participation in this program is another example of Eurofins' food safety expertise and commitment to brand protection.
"We are pleased to expand our certification portfolio in order to accommodate the growing demands for FSSC 22000 Certification," said Eurofins Food Safety Systems Director, Gary Smith. "FSSC 22000 is an internationally recognized scheme that affirms a supplier's food safety management systems meet the requirements of the food industry and outlets that distribute and sell these items."
For more information, please visit www.eurofinsus.com/food-safety
Eurofins Scientific is the world leader in food, environment and pharmaceutical products testing. It is also one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services. In addition, Eurofins is one of the key emerging players in specialty clinical diagnostic testing in Europe and the USA. With 20,000 staff in around 200 laboratories across 38 countries, Eurofins offers a portfolio of over 130,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products, as well as for innovative clinical diagnostic. The Group provides its customers with high-quality services, accurate results on time and expert advice by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.
As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.
The shares of Eurofins Scientific are listed on the Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).
SOURCE Eurofins Scientific